Evaluation of therapeutic sensitivity of retinal ganglion cells to targeted peptide bioregulator in culture

To study how therapeutically sensitive retinal cell culture is to the peptide bioregulator isolated from cattle retina (Retinalamin) in models of glaucomatous optic neuropathy (GON). The cells were isolated from the retinae separated from newborn mice. Cell sheets were disaggregated and transformed...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vestnik oftal'mologii Jg. 135; H. 1; S. 84
Hauptverfasser: Avetisov, S E, Erichev, V P, Fyodorov, A A, Yaremenko, T V, Murakhovskaya, Yu K
Format: Journal Article
Sprache:Englisch
Russisch
Veröffentlicht: Russia (Federation) 2019
ISSN:0042-465X
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract To study how therapeutically sensitive retinal cell culture is to the peptide bioregulator isolated from cattle retina (Retinalamin) in models of glaucomatous optic neuropathy (GON). The cells were isolated from the retinae separated from newborn mice. Cell sheets were disaggregated and transformed into a suspension. Removal of the off-target cell population was done by adding antibodies to deplete the cells with CD48 marker, and magnetic microbeads that attach to them. Selection of ganglion cells and obtainment of its enriched fraction was done by immunomagnetic separation. To assess the toxicity of Retinalamin, a cytotoxic test was performed on the culture of skin fibroblasts with sequential dilution of the drug into concentrations of 5.0-0.009 mg/mL. The cells were seeded at 5000 per plate well and exposed to the drug for 24 hours. To study the excitotoxic damage, the first group of plate wells with retinal cells had solution of sodium glutamate added in concentration of 20 mM, Retinalamin was added into the second group of wells in concentration of 1.25 mg/mL; both substances were added into the third group of wells. The control group consisted of intact plate wells. The cells were exposed to substances for 24 hours. Cell vitality was then evaluated using colorimetry. Optic density was measured using an automatic photometer with detection wavelength of λ=490 nm. The cell culture achieved by immunomagnetic separation is mixed and consists of ganglion and glial cells. Retinalamin does not display significant cytotoxicity in any of the studied concentrations. The excitotoxic damage caused significant decrease of the amount of viable cells in the culture (9% of the control wells). The concomitant addition of glutamate and 1.25 mg/mL Retinalamin resulted in a 51.6% increase in the amount of viable cells. The intergroup differences were statistically significant by Student's t-test. Retinalamin is not cytotoxic. The concomitant addition of glutamate and Retinalamin reliably decreases the toxic action of glutamate on isolated retinal cells.
AbstractList To study how therapeutically sensitive retinal cell culture is to the peptide bioregulator isolated from cattle retina (Retinalamin) in models of glaucomatous optic neuropathy (GON). The cells were isolated from the retinae separated from newborn mice. Cell sheets were disaggregated and transformed into a suspension. Removal of the off-target cell population was done by adding antibodies to deplete the cells with CD48 marker, and magnetic microbeads that attach to them. Selection of ganglion cells and obtainment of its enriched fraction was done by immunomagnetic separation. To assess the toxicity of Retinalamin, a cytotoxic test was performed on the culture of skin fibroblasts with sequential dilution of the drug into concentrations of 5.0-0.009 mg/mL. The cells were seeded at 5000 per plate well and exposed to the drug for 24 hours. To study the excitotoxic damage, the first group of plate wells with retinal cells had solution of sodium glutamate added in concentration of 20 mM, Retinalamin was added into the second group of wells in concentration of 1.25 mg/mL; both substances were added into the third group of wells. The control group consisted of intact plate wells. The cells were exposed to substances for 24 hours. Cell vitality was then evaluated using colorimetry. Optic density was measured using an automatic photometer with detection wavelength of λ=490 nm. The cell culture achieved by immunomagnetic separation is mixed and consists of ganglion and glial cells. Retinalamin does not display significant cytotoxicity in any of the studied concentrations. The excitotoxic damage caused significant decrease of the amount of viable cells in the culture (9% of the control wells). The concomitant addition of glutamate and 1.25 mg/mL Retinalamin resulted in a 51.6% increase in the amount of viable cells. The intergroup differences were statistically significant by Student's t-test. Retinalamin is not cytotoxic. The concomitant addition of glutamate and Retinalamin reliably decreases the toxic action of glutamate on isolated retinal cells.
To study how therapeutically sensitive retinal cell culture is to the peptide bioregulator isolated from cattle retina (Retinalamin) in models of glaucomatous optic neuropathy (GON).PURPOSETo study how therapeutically sensitive retinal cell culture is to the peptide bioregulator isolated from cattle retina (Retinalamin) in models of glaucomatous optic neuropathy (GON).The cells were isolated from the retinae separated from newborn mice. Cell sheets were disaggregated and transformed into a suspension. Removal of the off-target cell population was done by adding antibodies to deplete the cells with CD48 marker, and magnetic microbeads that attach to them. Selection of ganglion cells and obtainment of its enriched fraction was done by immunomagnetic separation. To assess the toxicity of Retinalamin, a cytotoxic test was performed on the culture of skin fibroblasts with sequential dilution of the drug into concentrations of 5.0-0.009 mg/mL. The cells were seeded at 5000 per plate well and exposed to the drug for 24 hours. To study the excitotoxic damage, the first group of plate wells with retinal cells had solution of sodium glutamate added in concentration of 20 mM, Retinalamin was added into the second group of wells in concentration of 1.25 mg/mL; both substances were added into the third group of wells. The control group consisted of intact plate wells. The cells were exposed to substances for 24 hours. Cell vitality was then evaluated using colorimetry. Optic density was measured using an automatic photometer with detection wavelength of λ=490 nm.MATERIAL AND METHODSThe cells were isolated from the retinae separated from newborn mice. Cell sheets were disaggregated and transformed into a suspension. Removal of the off-target cell population was done by adding antibodies to deplete the cells with CD48 marker, and magnetic microbeads that attach to them. Selection of ganglion cells and obtainment of its enriched fraction was done by immunomagnetic separation. To assess the toxicity of Retinalamin, a cytotoxic test was performed on the culture of skin fibroblasts with sequential dilution of the drug into concentrations of 5.0-0.009 mg/mL. The cells were seeded at 5000 per plate well and exposed to the drug for 24 hours. To study the excitotoxic damage, the first group of plate wells with retinal cells had solution of sodium glutamate added in concentration of 20 mM, Retinalamin was added into the second group of wells in concentration of 1.25 mg/mL; both substances were added into the third group of wells. The control group consisted of intact plate wells. The cells were exposed to substances for 24 hours. Cell vitality was then evaluated using colorimetry. Optic density was measured using an automatic photometer with detection wavelength of λ=490 nm.The cell culture achieved by immunomagnetic separation is mixed and consists of ganglion and glial cells. Retinalamin does not display significant cytotoxicity in any of the studied concentrations. The excitotoxic damage caused significant decrease of the amount of viable cells in the culture (9% of the control wells). The concomitant addition of glutamate and 1.25 mg/mL Retinalamin resulted in a 51.6% increase in the amount of viable cells. The intergroup differences were statistically significant by Student's t-test.RESULTSThe cell culture achieved by immunomagnetic separation is mixed and consists of ganglion and glial cells. Retinalamin does not display significant cytotoxicity in any of the studied concentrations. The excitotoxic damage caused significant decrease of the amount of viable cells in the culture (9% of the control wells). The concomitant addition of glutamate and 1.25 mg/mL Retinalamin resulted in a 51.6% increase in the amount of viable cells. The intergroup differences were statistically significant by Student's t-test.Retinalamin is not cytotoxic. The concomitant addition of glutamate and Retinalamin reliably decreases the toxic action of glutamate on isolated retinal cells.CONCLUSIONRetinalamin is not cytotoxic. The concomitant addition of glutamate and Retinalamin reliably decreases the toxic action of glutamate on isolated retinal cells.
Author Murakhovskaya, Yu K
Yaremenko, T V
Avetisov, S E
Fyodorov, A A
Erichev, V P
Author_xml – sequence: 1
  givenname: S E
  surname: Avetisov
  fullname: Avetisov, S E
  organization: Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021; I.M. Sechenov First Moscow State Medical University, Department of Ophthalmology, 8-2 Trubetskaya St., Moscow, Russian Federation, 119991
– sequence: 2
  givenname: V P
  surname: Erichev
  fullname: Erichev, V P
  organization: Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021
– sequence: 3
  givenname: A A
  surname: Fyodorov
  fullname: Fyodorov, A A
  organization: Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021
– sequence: 4
  givenname: T V
  surname: Yaremenko
  fullname: Yaremenko, T V
  organization: I.M. Sechenov First Moscow State Medical University, Department of Ophthalmology, 8-2 Trubetskaya St., Moscow, Russian Federation, 119991
– sequence: 5
  givenname: Yu K
  surname: Murakhovskaya
  fullname: Murakhovskaya, Yu K
  organization: I.M. Sechenov First Moscow State Medical University, Department of Ophthalmology, 8-2 Trubetskaya St., Moscow, Russian Federation, 119991
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30830079$$D View this record in MEDLINE/PubMed
BookMark eNo1kD1PwzAYhD0U0VL6DxDyyBLw68ROMqKqfEiVWEBii1znTTA4cfBHJf49rSjTDffodHcXZDa6EQm5AnYLJYC8c11UdlCcQQ25YABVMSMLxgqeFVK8z8kqhE_GGBRCQinPyTxnVc5YWS_I12avbFLRuJG6jsYP9GrCFI2mAcdgotmb-HO0PEYzKkt7Nfb2iGu0NtDoaFS-x4gtnXCKpkW6M85jn6yKzlNzIJONyeMlOeuUDbg66ZK8PWxe10_Z9uXxeX2_zTQcJmRSgxYCOl0jg5K1TBdYiqropJaybTnXNRRK847vuo4LrkDqIkdVSpAC8pwvyc1f7uTdd8IQm8GEY1s1okuh4VCVtShrzg7o9QlNuwHbZvJmUP6n-T-I_wLcHGw6
ContentType Journal Article
DBID NPM
7X8
DOI 10.17116/oftalma201913501184
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
DocumentTitleAlternate Otsenka terapevticheskoĭ chuvstvitel'nosti ganglioznykh kletok setchatki v kul'ture k targetnomu peptidnomu bioreguliatoru
ExternalDocumentID 30830079
Genre English Abstract
Journal Article
GroupedDBID .GJ
53G
ALMA_UNASSIGNED_HOLDINGS
F5P
NPM
VCL
VIT
VME
7X8
ID FETCH-LOGICAL-c1019-6c1c551fc9e0170d0c4e7584f6c66dd22c914ac2f2bff252a16c43ea761651332
IEDL.DBID 7X8
ISSN 0042-465X
IngestDate Sun Nov 09 05:11:33 EST 2025
Thu Apr 03 06:54:34 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
Russian
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1019-6c1c551fc9e0170d0c4e7584f6c66dd22c914ac2f2bff252a16c43ea761651332
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 30830079
PQID 2187957920
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2187957920
pubmed_primary_30830079
PublicationCentury 2000
PublicationDate 2019-00-00
20190101
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – year: 2019
  text: 2019-00-00
PublicationDecade 2010
PublicationPlace Russia (Federation)
PublicationPlace_xml – name: Russia (Federation)
PublicationTitle Vestnik oftal'mologii
PublicationTitleAlternate Vestn Oftalmol
PublicationYear 2019
SSID ssj0001456176
Score 2.07455
Snippet To study how therapeutically sensitive retinal cell culture is to the peptide bioregulator isolated from cattle retina (Retinalamin) in models of glaucomatous...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 84
Title Evaluation of therapeutic sensitivity of retinal ganglion cells to targeted peptide bioregulator in culture
URI https://www.ncbi.nlm.nih.gov/pubmed/30830079
https://www.proquest.com/docview/2187957920
Volume 135
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8MwDI6AceDCQ7zGS0HiWm1J07Q5IYQ2cWHaAaTeqiwPNAHraDd-P3baMS5ISFwqtU3U1nZtx7H9EXIjMsEcFyYyzCSRwBrdieZx5L1HayetVz6ATaSjUZbnatwG3Oo2rXKlE4OitqXBGHmPB1jsVPH-7fwjQtQo3F1tITQ2SScGVwalOs2zdYwFvYOALxeqUIRM8rZ6LmVM9kDP6bd3DSZQMdxfY9ji9Dc_M9ib4d5_33Sf7LaeJr1rROOAbFTLQ_I6-O7uTUtPf1Rf0RpT2RssCbyF1Y04_0VjoS8MxxB_TRclbZLHnaVzzIixjk6mZdVA2pcVncLI0M3DHZHn4eDp_iFq8RaAUUCDSCK_EuaNcthVx_aNcLCcEF4aKa3l3CgmtOGeT7znCddMGhE7nUomESaGH5OtWTlzp4TqNLETWFk6FWcCCQx6xMMVONdSCtUl1yvaFSDP-AV65splXayp1yUnDQOKedN4o4jBXwSfRp39YfY52cHnNtGSC9Lx8De7S7JtPhfTuroKggLH0fjxC4HxyZY
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+therapeutic+sensitivity+of+retinal+ganglion+cells+to+targeted+peptide+bioregulator+in+culture&rft.jtitle=Vestnik+oftal%27mologii&rft.au=Avetisov%2C+S+E&rft.au=Erichev%2C+V+P&rft.au=Fyodorov%2C+A+A&rft.au=Yaremenko%2C+T+V&rft.date=2019-01-01&rft.issn=0042-465X&rft.volume=135&rft.issue=1&rft.spage=84&rft_id=info:doi/10.17116%2Foftalma201913501184&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0042-465X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0042-465X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0042-465X&client=summon